跳至主要内容
临床试验/KCT0001815
KCT0001815招募中未知

clinical trial research to evaluate the safety and efficacy of domestic absorbable membrane(LYSOGEDE®) and foreign absorbable membrane(Bio-Gide®) used the most in clinical field.

Ministry of Health & Welfare0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
66

研究概览

简要总结

RESULTS - Evaluation of dimensional changes The results for the dimensional changes in master casts are displayed in Table 2. The mean dimensional difference between the 1-week and 6-month casts was -0.98 mm in the treatment group and -1.01 mm in the control group (P=0.050). The cast volume was lower at 6 months than at 1 week in both the treatment and control groups. - Quantity of bone tissue in CBCT The results for the normalized quantity of bone tissue (Q6/Q2) in the CBCT data are presented in Table 2. The mean percentage was 91.6% in the treatment group and 91.5% in the control group (P=0.050). There was less quantity of bone tissue at 6 months than at 1 week in both the treatment and control groups. - Changes in width and height in CBCT The changes in the width of the center of the extraction socket in CBCT data are displayed in Table 2. The mean difference in width between the V2 and V6 images was -1.7 mm in the treatment group and -2.1 mm in the control group (P=0.050).

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 o Limit(—)
性别
All

入选标准

  • ? Only adults over 20 years old
  • ? need a tooth extraction due to periodontal disease in the maxilla or mandible
  • - patients have clinical attachment loss of more than 5mm in the area, grade 3 in tooth mobility
  • - patients required bone grafts for therapeutic purposes, such as in the area of the implant

排除标准

  • ? pregnant woman
  • ? Uncontrolled hypertension or with diabetes
  • ? In patients with a history or current malignant disease jaws
  • ? Serious cardiovascular disease, respiratory disease, heart disease, liver disease, digestive disorders, blood disorders and neurological disorders • Patients with Psychiatric Disorders and merging
  • ? Patients with hyperthyroidism or hypothyroidism.
  • ? Patients with a history of drug allergy
  • ? Depression or anxiety disorder altitude, and the patient is determined to influence the efficacy assessment
  • ? Or patients with a history of drug or alcohol abuse within 1 year currently Abuse
  • ? Patients deemed suitable by the investigator or research enforcer this study

研究者

相似试验